ReviewJournal of substance abuse treatment2021
Characterizing trends in methamphetamine-related health care use when there is no ICD code for "methamphetamine use disorder".
Review in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 25 citations in OpenAlex.
- Comparison of statewide substance use disorder prevalence estimates from survey data vs electronic health record data.Drug and alcohol dependence · 2026Article
- Three-year cardiovascular risk prediction among people who use cocaine or methamphetamine.Drug and alcohol dependence reports · 2026Article
- Illicit stimulants and ventricular arrhythmias: a longitudinal cohort study.European heart journal · 2025Article
- Evaluating markers for methamphetamine use in electronic health records.Drug and alcohol dependence · 2025Article
- Prescribed medications for patients with amphetamine-type stimulant use disorder seen in rural-serving Pacific Northwest primary care clinics.Addiction science & clinical practice · 2025Article
- The Role of Mental Health, Recent Trauma, and Suicidal Behavior in Officer-Involved Shootings: A Public Health Perspective.International journal of environmental research and public health · 2025Article
- Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization.Journal of substance use and addiction treatment · 2024Article
- U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019.Drug and alcohol dependence · 2024Article
- Prenatal methamphetamine use increases risk of adverse maternal and neonatal outcomes.American journal of obstetrics and gynecology · 2024Article
- Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019.Drug and alcohol dependence reports · 2024Article
- Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net Hospital.Journal of general internal medicine · 2024Article
- Using the Alcohol, Smoking and Substance Involvement Screening Test to predict substance-related hospitalisation after release from prison: A cohort study.Addiction (Abingdon, England) · 2024Article
- Temporal Trends in Substance Use and Cardiovascular Disease-Related Mortality in the United States.Journal of the American Heart Association · 2024Article
- Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants.Substance use & misuse · 2024Observational
- Minnesota Data Sharing May Be Model For Near-Real-Time Tracking Of Drug Overdose Hospital And ED Trends.Health affairs (Project Hope) · 2023Article
- Substance Use in Pregnancy and its Association With Cardiovascular Events.JACC. Advances · 2023Article
- Article
- Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008-2018.BMC emergency medicine · 2022Article
- Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023.Substance use : research and treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
BACKGROUND AND
aimsThe recent surge in methamphetamine use highlights the need for timely data on its health effects and healthcare service use impact. However, there is no ICD code for methamphetamine use. This study quantifies the positive predictive value of ICD-9-CM and ICD-10-CM psychostimulant codes for methamphetamine use.
methodsA retrospective chart review of 220 adults aged 18 and older who had an inpatient admission with a psychostimulant-associated billing diagnosis at an urban safety-net hospital. Diagnoses were categorized as either methamphetamine-related or involving another specific psychostimulant. The positive predictive value of both ICD-9-CM or ICD-10-CM psychostimulant diagnosis codes for methamphetamine use was calculated.
resultsICD-9-CM and ICD-10-CM psychostimulant codes had high positive predictive values of 78.2% (95% CI 70.3%-86.0%) and 85.5% (95% CI 78.8%-92.1%), respectively, for methamphetamine use. The most common non-methamphetamine psychostimulant in our cohort was khat, a cathinone-containing plant native to East Africa, accounting for psychostimulant-related diagnosis in 16 of the 220 hospitalizations.
conclusionsThe high predictive values of psychostimulant codes for methamphetamine use support the application of administrative data in measuring methamphetamine-related healthcare use, as well as co-morbid health conditions and treatment patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.